BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Poly Medicure Ltd. Share Price

NSE
BSE

NSE : POLYMED

BSE : 531768

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹1,727.10

High

₹1,777.00

Price Summary

Previous Close ₹1,746.00
Day's Range ₹1,727.10 - ₹1,777.00
Open ₹1,741.80
52 Week Range ₹1,182.00 - ₹2,279.80
Volume 94,141
Market Cap ₹0.02
Previous Close ₹1,742.00
Day's Range ₹1,727.80 - ₹1,775.00
Open ₹1,736.30
52 Week Range ₹1,184.00 - ₹2,275.30
Volume 11,762
Market Cap ₹0.02

Stocks Summary

Trade Value ( ₹ in Lacs) 1,643.70
Market Cap (₹ in Mn) 0.02
Dividend Yield(%) 0.20
Price/Earning (TTM) 54.68
TTM EPS (₹) 31.78
P/E Ratio 67.10
Book Value(₹) 5.67
PAT Margin (%) 20.19
Face Value (₹) 5.00
ROCE(%) 20.37
Trade Value ( ₹ in Lacs) 204.89
Market Cap (₹ in Mn) 0.02
Dividend Yield(%) 0.20
Price/Earning (TTM) 54.68
TTM EPS (₹) 31.78
P/E Ratio 67.10
Book Value(₹) 5.67
PAT Margin (%) 20.19
Face Value (₹) 5.00
ROCE(%) 20.37

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 16698.32 4408.28
Expenses N/A N/A
PBT 4525.15 1228.49
Operating profit 0.0 0.0
Net profit 3385.57 918.34

Shareholding Pattern

Promoters (% Holding)

62.42%

Mutual funds (% Holding)

8.84%

Non-Institution (% Holding)

16.08%

FI/Banks/Insurance (% Holding)

3.34%

Government (% Holding)

0.00%

FII

5.92%

About Poly Medicure Ltd.

Founded 1995
Managing Director Himanshu Baid
NSE Symbol POLYMED

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,49,047.54 1,910.25 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,77,179.04 6,765.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,57,803.57 4,744.00 3,287.30 - 3,287.30
Apollo Hospitals Enterprise Ltd. 1,25,057.42 8,817.50 6,696.50 - 6,696.50
Cipla Ltd. 1,17,642.47 1,462.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,12,368.23 1,373.85 1,148.40 - 1,148.40
Max Healthcare Institute Ltd. 1,09,728.37 1,145.00 903.00 - 903.00
Zydus Lifesciences Ltd. 1,09,690.51 1,113.40 835.50 - 835.50
Lupin Ltd. 1,09,676.37 2,450.00 1,836.80 - 1,836.80
Mankind Pharma Ltd. 1,02,728.62 2,506.20 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Jun
22
2026
EQUITY Posted on Jun 22nd 2026

Poly Medicure submits intimation for schedule of investor meet

Pursuant to Regulation 30 and applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A, Poly Medicure has informed that the Company's officials will hold one-on-one meeting with analyst/investor on Thursday, 25th June 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
May
29
2026
EQUITY Posted on May 29th 2026

Poly Medicure submits transcript of conference call

Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Poly Medicure has submitted Transcript of the investor Meet/Call held on 25th May, 2026, at 17:00 pm (IST) on the Audited Financial Results of the Company for the quarter and Year ended, 31st March, 2026, on Standalone and Consolidated basis, which were considered and approved by the Board of Directors of the Company, at its meeting held on 25th May, 2026.

The above information is a part of company’s filings submitted to BSE. 

Read More
May
20
2026
EQUITY Posted on May 20th 2026

Poly Medicure informs about conference call

Poly Medicure has informed that an earnings call will be held on Monday, 25th May, 2026 at 05:00 PM India time for discussing the Audited Financial Results of the Company for the quarter and Year ended 31st March, 2026. Link for joining, Dial in and other details of the call are enclosed.
The above information is a part of company’s filings submitted to BSE.
Read More
Jul
2
2026
EQUITY Posted on Jul 2nd 2026

Alkem Laboratories informs about newspaper advertisement

Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI LODR Regulations, Alkem Laboratories has informed that it enclosed a copy of advertisement published in today's newspapers, Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 52nd Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Read More
Jul
2
2026
EQUITY Posted on Jul 2nd 2026

Dr. Lal PathLabs informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has attached the copy of newspaper advertisement(s), published in Financial Express and Jansatta on July 02, 2026, intimating about the dispatch of Notice of 32nd Annual General Meeting and Annual Report for FY 2025-26 to the Members of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Poly Medicure Ltd. ?

The current share price of Poly Medicure Ltd. is ₹1,746.00 as of 2026-07-03.

The market capitalisation of Poly Medicure Ltd. is ₹17,614.25 as of 2026-07-02.

The 1-year return of Poly Medicure Ltd. is -524.00% as of 2026-07-03.

The P/E ratio of Poly Medicure Ltd. is 67.10 as of 2026-07-03.

The 52-week high and low of Poly Medicure Ltd. are ₹2,279.80 and ₹1,182.00, respectively, as of 2026-07-03.

The dividend yield of Poly Medicure Ltd. is 0.2014% as of2026-07-02.

You can buy Poly Medicure Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Poly Medicure Ltd. is Himanshu Baid.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore